133 related articles for article (PubMed ID: 36123900)
1. Apatinib and temozolomide in children with recurrent ependymoma: A case report.
Zhao S; Shen Z; Li J; Shi L; Zhang N
Medicine (Baltimore); 2022 Sep; 101(37):e30529. PubMed ID: 36123900
[TBL] [Abstract][Full Text] [Related]
2. Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas.
Yao H; Liu J; Zhang C; Shao Y; Li X; Feng M; Wang X; Gan W; Zhou Y; Huang Y
J Clin Neurosci; 2021 Aug; 90():82-88. PubMed ID: 34275586
[TBL] [Abstract][Full Text] [Related]
3. Combining apatinib and temozolomide for brainstem glioblastoma: a case report and review of literature.
Zhu Y; Zhao L; Xu Y; Zhan W; Sun X; Xu X
Ann Palliat Med; 2022 Jan; 11(1):394-400. PubMed ID: 35144430
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy with anlotinib for patient with recurrent glioblastoma: A case report and literature review.
Lv Y; Zhang J; Liu F; Song M; Hou Y; Liang N
Medicine (Baltimore); 2019 May; 98(22):e15749. PubMed ID: 31145289
[TBL] [Abstract][Full Text] [Related]
5. Effects of Apatinib combined with Temozolomide on levels of sPD-1 and sPD-L1 in patients with drug-resistant recurrent glioblastoma.
Kuang RZ; Wang J; Wang YC; Tang XP
Clinics (Sao Paulo); 2024; 79():100376. PubMed ID: 38733690
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
Chamberlain MC; Johnston SK
Cancer; 2009 Oct; 115(20):4775-82. PubMed ID: 19569246
[TBL] [Abstract][Full Text] [Related]
7. Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review.
Fujiwara Y; Manabe H; Izumi B; Shima T; Adachi N
Eur Spine J; 2018 Jul; 27(Suppl 3):421-425. PubMed ID: 29270703
[TBL] [Abstract][Full Text] [Related]
8. Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report.
Zhao M; Ma H; Cheng P; Yang H; Zhao Y; Han Q
Medicine (Baltimore); 2022 Dec; 101(49):e32156. PubMed ID: 36626518
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.
Rudà R; Bosa C; Magistrello M; Franchino F; Pellerino A; Fiano V; Trevisan M; Cassoni P; Soffietti R
Neuro Oncol; 2016 Feb; 18(2):261-8. PubMed ID: 26323606
[TBL] [Abstract][Full Text] [Related]
10. Apatinib treatment for symptomatic pseudoprogression after standard treatment for glioblastoma multiforme: a case report.
Wang Z; Du F; Sun Y; Guo Y; Song B; Wang Y; Shi X; Jiang W
Ann Palliat Med; 2019 Nov; 8(5):752-757. PubMed ID: 31865735
[TBL] [Abstract][Full Text] [Related]
11. Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report.
Liu J; Zheng Y; Xu N
Medicine (Baltimore); 2019 Feb; 98(5):e14328. PubMed ID: 30702616
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic ependymoma.
Lombardi G; Pambuku A; Bellu L; Della Puppa A; Rumanò L; Gardiman MP; Pomerri F; Zagonel V
Chemotherapy; 2013; 59(3):176-80. PubMed ID: 24192541
[TBL] [Abstract][Full Text] [Related]
13. Apatinib in recurrent anaplastic meningioma: a retrospective case series and systematic literature review.
Wang Y; Li W; Jing N; Meng X; Zhou S; Zhu Y; Xu J; Tao R
Cancer Biol Ther; 2020 Jul; 21(7):583-589. PubMed ID: 32212907
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
15. Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma.
Ge J; Li C; Xue F; Qi S; Gao Z; Yu C; Zhang J
Front Oncol; 2020; 10():601175. PubMed ID: 33634023
[TBL] [Abstract][Full Text] [Related]
16. Significant efficacy and well safety of apatinib combined with radiotherapy in NSCLC: Case report.
Zhao C; Zhang Q; Qiao W
Medicine (Baltimore); 2017 Dec; 96(50):e9276. PubMed ID: 29390380
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of apatinib in desmoplastic small round cell tumor: a case report and literature review.
Shi C; Feng Y; Zhang LC; Ding DY; Yan MY; Pan L
BMC Cancer; 2018 Mar; 18(1):338. PubMed ID: 29587657
[TBL] [Abstract][Full Text] [Related]
18. Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report.
Yan H; Li X; Peng Y; Zhang P; Zou N; Liu X
Medicine (Baltimore); 2020 Oct; 99(43):e22925. PubMed ID: 33120847
[TBL] [Abstract][Full Text] [Related]
19. The use of apatinib in treating primary pleural synovial sarcoma: A case report.
Chen S; Zhang K; Wan X; Chen Y; Ma S; Deng Q
Medicine (Baltimore); 2019 Dec; 98(51):e18382. PubMed ID: 31861000
[TBL] [Abstract][Full Text] [Related]
20. "One week on-one week off": efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center.
Galldiks N; Berhorn T; Blau T; Dunkl V; Fink GR; Schroeter M
J Neurooncol; 2013 Apr; 112(2):209-15. PubMed ID: 23299464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
